ArticleThe Journal of investigative dermatology2022

Uncovering the Potential of Phosphatidylinositol 3-Kinase Inhibitors in Cutaneous T-Cell Lymphoma: Insights from High-Throughput In Vitro Screenings.

Amber Loren Ong King et al.PubMed ↗Publisher ↗

No numbers read from the abstract.